Pfizer’s Dividend Freeze Raises a Bigger Question About Its Cash Flow - 24/7 Wall St.
Pfizer’s Dividend Freeze Raises a Bigger Question About Its Cash Flow 24/7 Wall St.
Covered in this story
What has happened since
- Pfizer is up 2.3% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Pfizer
- Cantor Fitzgerald: $28.3 → $28 by Oct 2027 · Neutral via TIKR.com
- Bank of America: $28.3 → $29 by Oct 2027 · Neutral via TIKR.com
- JPMorgan: $28.3 → $30 by Oct 2027 · Neutral via The Globe and Mail
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PFE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Pfizer →Dalsna Finance is currently tracking 50 stories mentioning Pfizer, the earliest published 18 Jun 2026.
Summary aggregated from Google News's public RSS feed. The full reporting belongs to Google News — please read it on their site.